Pancreatic cancer (PC) remains one of the deadliest cancers worldwide, and has a poor,
five-year survival rate of 5%. Although complete surgical resection is the only curative …

Background Pancreatic cancer, primarily pancreatic ductal adenocarcinoma (PDAC),
accounts for 2.4% of cancer diagnoses and 5.8% of cancer death annually. Early diagnoses …

Background and Aims Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at a
late stage. Little is known about the incidental finding of early-stage PDAC. The aim of the …

OBJECTIVE. The purpose of this study was to compare comprehensive CT and MRI in the
presurgical evaluation of pancreatic cancer. MATERIALS AND METHODS. Thirty-eight …

PURPOSE Pancreatic cancer is an aggressive malignancy with patients often experiencing
nonspecific symptoms before diagnosis. This study evaluates a machine learning approach …

Purpose To determine the diagnostic performance of fluorine 18 fluorodeoxyglucose (FDG)
positron emission tomography (PET)/magnetic resonance (MR) imaging in the preoperative …

Interest in radical surgery to achieve complete resection and improve long-term survival in
patients undergoing pancreatoduodenectomy for ductal adenocarcinoma has been …

Introduction. Imaging has a decisive role in the diagnosis and staging of pancreatic cancer,
the most used imaging methods being computed tomography, magnetic resonance imaging …

Background This systematic review aimed to determine the accuracy of imaging modalities
to predict resectability and R0 resection for borderline resectable (BRPC) or locally …

Purpose To test ultrasonographic (US) imaging with vascular endothelial growth factor
receptor type 2 (VEGFR2)-targeted microbubble contrast material for the detection of …